Literature DB >> 6271984

Induction of neurite outgrowth in the IMR-32 human neuroblastoma cell line by nerve growth factor.

C P Reynolds, J R Perez-Polo.   

Abstract

The nerve growth factor protein (NGF) stimulates neurite outgrowth form embryonic sensory ganglia and sympathetic ganglia at all stages of development. In addition, NGF is required for the maintenance of the differentiated state in adult sympathetic ganglia. A clonal cell line, IMR-32, derived from a human neuroblastoma was found to contain a population of cells that respond to NGF by exhibiting morphological differentiation. The effect of NGF on these cells is compared with that of other agents known to induce differentiation of IMR-32, including glioma-conditioned media.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6271984     DOI： 10.1002/jnr.490060307

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN： 0360-4012            Impact factor:   4.164


  10 in total

1.  The reverse transforming effects of nerve growth factor on five human neurogenic tumor cell lines: in vitro results.

Authors:  M J Yaeger; A Koestner; K Marushige; Y Marushige
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  Differential expression of kcnq2 splice variants: implications to m current function during neuronal development.

Authors:  J S Smith; C A Iannotti; P Dargis; E P Christian; J Aiyar
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

3.  Steroid requirements for regulation of the alpha4 subunit of the GABA(A) receptor in an in vitro model.

Authors:  Xiangping Zhou; Sheryl S Smith
Journal:  Neurosci Lett       Date:  2006-11-01       Impact factor: 3.046

4.  Morphologic, cytochemical and neurochemical characterization of the human medulloblastoma cell line TE671.

Authors:  P M Zeltzer; S L Schneider; D D Von Hoff
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

5.  The use of nerve growth factor as a reverse transforming agent for the treatment of neurogenic tumors: in vivo results.

Authors:  M J Yaeger; A Koestner; K Marushige; Y Marushige
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

6.  An effect of nerve growth factor on parasympathetic neurite outgrowth.

Authors:  F Collins; A Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

7.  Human neuroblastoma cells acquire regulated secretory properties and different sensitivity to Ca2+ and alpha-latrotoxin after exposure to differentiating agents.

Authors:  E Sher; S Denis-Donini; A Zanini; C Bisiani; F Clementi
Journal:  J Cell Biol       Date:  1989-06       Impact factor: 10.539

8.  Discovery and preclinical characterization of novel small molecule TRK and ROS1 tyrosine kinase inhibitors for the treatment of cancer and inflammation.

Authors:  Ramesh Narayanan; Muralimohan Yepuru; Christopher C Coss; Zhongzhi Wu; Matthew N Bauler; Christina M Barrett; Michael L Mohler; Yun Wang; Juhyun Kim; Linda M Snyder; Yali He; Nelson Levy; Duane D Miller; James T Dalton
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

Review 9.  Regulation of the differentiation of PC12 pheochromocytoma cells.

Authors:  K Fujita; P Lazarovici; G Guroff
Journal:  Environ Health Perspect       Date:  1989-03       Impact factor: 9.031

10.  A high-content morphological screen identifies novel microRNAs that regulate neuroblastoma cell differentiation.

Authors:  Zhenze Zhao; Xiuye Ma; Tzu-Hung Hsiao; Gregory Lin; Adam Kosti; Xiaojie Yu; Uthra Suresh; Yidong Chen; Gail E Tomlinson; Alexander Pertsemlidis; Liqin Du
Journal:  Oncotarget       Date:  2014-05-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.